Endothelial cell activation

Endothelial cell activation refers to a complex and dynamic process whereby vascular endothelial cells shift from a quiescent (resting) state to an activated state in response to stimuli such as pro-inflammatory cytokines (e.g., TNF-alpha), turbulent flow, hypoxia, or environmental stresses[1][3][7]. Upon activation, endothelial cells upregulate cell adhesion molecules (such as VCAM-1, ICAM-1, and E-selectin) and secrete cytokines and chemokines involved in leukocyte recruitment, immune response, angiogenesis (formation of new blood vessels), and vascular remodeling[1][3][8]. Activation also changes endothelial barrier properties and is a key feature of pathological states including inflammation, atherosclerosis, tumor angiogenesis, and infection[1][3][7][8]. Canonical molecular pathways involved in this process include the VEGF and Notch signaling pathways (critical in angiogenic activation/vascular sprouting), as well as activation of transcription factors such as NF-κB and AP-1 in response to inflammatory mediators[1][3][8]. Endothelial cell activation is a cellular process and not a single molecular target; therefore, drugs do not directly target "endothelial cell activation" per se, but instead may target signaling molecules and pathways involved in its regulation (e.g., VEGFRs, eNOS, TNF pathways)[1][3][7]. **Key context:** - "Endothelial cell activation" is not a distinct gene, protein, or canonical drug target—it is a process or cellular state. - It describes functional and phenotypic changes in endothelial cells in response to diverse stimuli, not a molecular entity[1][3][7][8]. - As such, it cannot be assigned a canonical abbreviation, formal molecular classification beyond “Other,” or a list of direct-interacting drugs. - Biomarkers (such as VCAM-1, ICAM-1, E-selectin, nitric oxide) are often used to monitor or infer activation status in research and clinical contexts[3][7]. **Conclusion:** "Endothelial cell activation" is a descriptive term for a physiological/pathological cellular state, not a molecular drug target or receptor; it is therefore not structured as a canonical target entry for drug targeting purposes[1][3][7][8].